 Aimmune Therapeutics Inc NASDAQ:AIMT major shareholder Health Science Us Holdi Nestle acquired 937,500 shares of the businesss stock in a transaction dated Wednesday, February 26th. The shares were bought at an average cost of 32.00 per share, for a total transaction of 30,000,000.00. The transaction was disclosed in a document filed with the SEC, which ... 